Kalaris Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold KLRS, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
9
Funds holding
$2020601
Total value held
Buying
7 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Raymond James Financial Inc | $685978 | 118887 | +30451 | +34.43% |
| 2 | Goldman Sachs Group Inc | $637602 | 110503 | +76200 | +222.14% |
| 3 | Morgan Stanley | $221245 | 38344 | +10396 | +37.20% |
| 4 | Blackrock, Inc. | $207968 | 36043 | -2411 | -6.27% |
| 5 | State Street Corp | $152963 | 26510 | +1100 | +4.33% |
| 6 | Northern Trust Corp | $83371 | 14449 | +795 | +5.82% |
| 7 | Barclays Plc | $30466 | 5280 | — | NEW BUY |
| 8 | Royal Bank Of Canada | $1000 | 103 | — | NEW BUY |
| 9 | Citigroup Inc | $8 | 1 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.